MICHAEL JOHN PHELAN, M.D.
Medical Practice at Sleepy Hollow Ave, Hayward, CA
License number
California G73755
Category
Medical Practice
Type
Pediatrics
Address
Address
27303 Sleepy Hollow Ave, Hayward, CA 94545
Phone
(510) 454-1000
Personal information
See more information about MICHAEL JOHN PHELAN at radaris.comName
Address
Phone
423 Tharp Dr, Moraga, CA 94556
4237 Mustic Way, Rancho Cordova, CA 95655
46 Cantera, Santa Ana, CA 92703
5500 Tuxedo Ter, Los Angeles, CA 90068
5725 Pearl Dr, Paradise, CA 95969
Professional information
Dr. Michael J Phelan, Hayward CA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
Kaiser Permanente Medical Ctr
27400 Hesperian Blvd, Hayward 94545
(510) 784-4000 (Phone)
27400 Hesperian Blvd, Hayward 94545
(510) 784-4000 (Phone)
Certifications:
Pediatrics, 1994
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese, Spanish, Vietnamese
Hospitals:
Kaiser Permanente Medical Ctr
27400 Hesperian Blvd, Hayward 94545
Kaiser Permanente Hayward Medical Center
27400 Hesperian Blvd, Hayward 94545
27400 Hesperian Blvd, Hayward 94545
Kaiser Permanente Hayward Medical Center
27400 Hesperian Blvd, Hayward 94545
Education:
Medical School
Rosalind Franklin University Of Medicine Science/The Chicago Medical School
Graduated: 1990
Kaiser Fdn Hospital
Graduated: 1991
Graduated: 1994
Rosalind Franklin University Of Medicine Science/The Chicago Medical School
Graduated: 1990
Kaiser Fdn Hospital
Graduated: 1991
Graduated: 1994
Michael John Phelan, Hayward CA
Specialties:
Pediatrician
Address:
27400 Hesperian Blvd, Hayward, CA 94545
27303 Sleepy Hollow Ave South, Hayward, CA 94545
27303 Sleepy Hollow Ave South, Hayward, CA 94545
Education:
Doctor of Medicine
KFH San Francisco Medical Center - Residency - Pediatrics
KFH San Francisco Medical Center - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics
Michael John Phelan, Hayward CA
Specialties:
Pediatrics
Work:
Kaiser Foundation Hospital - Hayward
27400 Hesperian Blvd, Hayward, CA 94545 Hayward Medical Center
27303 Sleepy Hollow Ave S, Hayward, CA 94545
27400 Hesperian Blvd, Hayward, CA 94545 Hayward Medical Center
27303 Sleepy Hollow Ave S, Hayward, CA 94545
Education:
University of Chicago (1990)
Mutant Dna Polymerases
US Patent:
2013000, Jan 3, 2013
Filed:
Aug 31, 2012
Appl. No.:
13/600416
Inventors:
Marian PERIS - Belmont CA, US
Michael PHELAN - Hayward CA, US
Barnett B. ROSENBLUM - San Jose CA, US
Stephen P. HENDRICKS - Los Gatos CA, US
Michael PHELAN - Hayward CA, US
Barnett B. ROSENBLUM - San Jose CA, US
Stephen P. HENDRICKS - Los Gatos CA, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
International Classification:
C12N 9/12
US Classification:
435194
Abstract:
Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.
Polymerase Compositions And Methods
US Patent:
2012032, Dec 20, 2012
Filed:
Jul 3, 2012
Appl. No.:
13/540935
Inventors:
Stephen P. HENDRICKS - Los Gatos CA, US
Michael PHELAN - Hayward CA, US
Marian PERIS - Belmont CA, US
Cheng-Yao CHEN - Carlsbad CA, US
Daniel MAZUR - San Diego CA, US
Xinzhan PENG - Carlsbad CA, US
Amy CASTILLO - Houston TX, US
Michael PHELAN - Hayward CA, US
Marian PERIS - Belmont CA, US
Cheng-Yao CHEN - Carlsbad CA, US
Daniel MAZUR - San Diego CA, US
Xinzhan PENG - Carlsbad CA, US
Amy CASTILLO - Houston TX, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
International Classification:
C12N 9/12, C12Q 1/68, C12N 1/00, C12P 19/34, C12N 15/54, C12N 15/63
US Classification:
435 61, 435194, 536 232, 435243, 435 915
Abstract:
Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.
Nucleotide Transient Binding For Sequencing Methods
US Patent:
8632975, Jan 21, 2014
Filed:
May 28, 2010
Appl. No.:
12/790760
Inventors:
Peter B. Vander Horn - Encinitas CA, US
Cheng-Yao Chen - Carlsbad CA, US
Guobin Luo - Oceanside CA, US
Michael Previte - Carlsbad CA, US
Jamshid Temirov - Germantown TN, US
Theo Nikiforov - Carlsbad CA, US
Zhaohui Zhou - San Ramon CA, US
Hongye Sun - Belmont CA, US
Yufang Wang - San Carlos CA, US
Stefanie Yukiko Nishimura - Mountain View CA, US
Hongyi Wang - Pearland TX, US
Marian Peris - Belmont CA, US
Barnett B. Rosenblum - San Jose CA, US
Michael Phelan - Hayward CA, US
Cheng-Yao Chen - Carlsbad CA, US
Guobin Luo - Oceanside CA, US
Michael Previte - Carlsbad CA, US
Jamshid Temirov - Germantown TN, US
Theo Nikiforov - Carlsbad CA, US
Zhaohui Zhou - San Ramon CA, US
Hongye Sun - Belmont CA, US
Yufang Wang - San Carlos CA, US
Stefanie Yukiko Nishimura - Mountain View CA, US
Hongyi Wang - Pearland TX, US
Marian Peris - Belmont CA, US
Barnett B. Rosenblum - San Jose CA, US
Michael Phelan - Hayward CA, US
Assignee:
Life Technologies Corporation - Carlsbad CA
International Classification:
C12Q 1/68
US Classification:
435 612, 435188
Abstract:
Provided herein are compositions and systems for use in polymerase-dependent, nucleotide transient-binding methods. The methods are useful for deducing the sequence of a template nucleic acid molecule and single nucleotide polymorphism (SNP) analyses. The methods rely on the fact that the polymerase transient-binding time for a complementary nucleotide is longer compared to that of a non-complementary nucleotide. The labeled nucleotides transiently-binds the polymerase in a template-dependent manner, but does not incorporate. The methods are conducted under any reaction condition that permits transient binding of a complementary or non-complementary nucleotide to a polymerase, and inhibits nucleotide incorporation.
Mutant Dna Polymerases
US Patent:
2010031, Dec 9, 2010
Filed:
May 28, 2010
Appl. No.:
12/790768
Inventors:
Marian PERIS - Belmont CA, US
Michael Phelan - Hayward CA, US
Barnett B. Rosenblum - San Jose CA, US
Stephen P. Hendricks - Los Gatos CA, US
Michael Phelan - Hayward CA, US
Barnett B. Rosenblum - San Jose CA, US
Stephen P. Hendricks - Los Gatos CA, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - Carlsbad CA
International Classification:
C12N 9/10, C07H 21/04, C12N 15/63, C12N 1/00, C12N 7/01, C07H 21/02
US Classification:
435193, 536 232, 4353201, 435243, 4352351
Abstract:
Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.
Polymerase Compositions & Methods
US Patent:
2011001, Jan 20, 2011
Filed:
Mar 26, 2010
Appl. No.:
12/748359
Inventors:
STEPHEN P. HENDRICKS - LOS GATOS CA, US
MICHAEL PHELAN - HAYWARD CA, US
MARIAN PERIS - BELMONT CA, US
CHENG-YAO CHEN - CARLSBAD CA, US
DANIEL MAZUR - SAN DIEGO CA, US
XINZHAN PENG - CARLSBAD CA, US
AMY CASTILLO - HOUSTON TX, US
MICHAEL PHELAN - HAYWARD CA, US
MARIAN PERIS - BELMONT CA, US
CHENG-YAO CHEN - CARLSBAD CA, US
DANIEL MAZUR - SAN DIEGO CA, US
XINZHAN PENG - CARLSBAD CA, US
AMY CASTILLO - HOUSTON TX, US
Assignee:
LIFE TECHNOLOGIES CORPORATION - CARLSBAD CA
International Classification:
C12Q 1/68, C12P 19/34, C12N 9/12, C12N 5/10, C12N 15/63, C07H 21/04
US Classification:
435 6, 435 911, 435194, 435325, 4353201, 536 232
Abstract:
Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.